tiprankstipranks
Avinger (AVGR)
NASDAQ:AVGR
Holding AVGR?
Track your performance easily

Avinger (AVGR) Earnings Date & Reports

946 Followers

Earnings Data

Report Date
Mar 06, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
-$0.4
Last Year’s EPS
-$0.89
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 07, 2024
|
% Change Since: -40.57%
|
Next Earnings Date:Mar 06, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted significant improvements in operating efficiency and progress in strategic initiatives, particularly in the coronary program and partnership with Zylox-Tonbridge. Despite a slight decline in revenue and a reduced sales team, overall financial performance improved, indicating positive momentum.
Company Guidance
During the third quarter 2024 earnings call for Avinger (symbol: AVGR), several key metrics and strategic initiatives were discussed. Avinger implemented a cost savings program that reduced overall head count by 24%, leading to improved efficiency in gross margin and revenue per sales head, with a field sales team now comprising 16 professionals. Despite the leaner sales team, the company maintained approximately 90% of revenue compared to the prior quarter, with total revenue for Q3 2024 at $1.7 million. Gross margin improved to 26% from 20% in the previous quarter, while operating expenses declined to $4.1 million. The company reported a net loss of $3.7 million, reflecting a 15% improvement compared to the previous quarter. Adjusted EBITDA showed a loss of $3.4 million, a 12% improvement from Q2 2024. The call also highlighted advancements in Avinger's coronary program, including progress on a coronary CTO crossing system, and emphasized their strategic partnership with Zylox-Tonbridge, aimed at penetrating the Greater China market.
Improved Operating Efficiency
Achieved notable improvements in operating efficiency, particularly in peripheral operations, with a significant reduction in operating costs and cash needs.
Strategic Realignment and Cost Savings
Implemented a cost savings program that reduced overall headcount by 24%, resulting in improved efficiency in gross margin and revenue per sales head.
Advancements in Coronary Program
Substantial progress on developing the first coronary product application, with successful completion of Phase III verification and validation testing for FDA IDE application.
Partnership with Zylox-Tonbridge
Strategic partnership for market access in China and cost-effective manufacturing, with regulatory filings expected by end of year and manufacturing scale-up anticipated by mid-2025.
Improved Financial Performance
Gross margin increased to 26% from 20% in the previous quarter. Operating expenses decreased to $4.1 million from $4.5 million, and net loss improved by 15% compared to the previous quarter.
---

Avinger (AVGR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AVGR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 06, 20252024 (Q4)
-0.40 / -
-0.89
Nov 07, 20242024 (Q3)
-2.03 / -1.82
-2.9237.67% (+1.10)
Aug 08, 20242024 (Q2)
-0.43 / -2.82
-8.8568.14% (+6.03)
May 15, 20242024 (Q1)
-1.35 / -2.49
-10.6576.62% (+8.16)
Mar 20, 20242023 (Q4)
0.64 / -0.89
-10.591.52% (+9.61)
Oct 26, 20232023 (Q3)
-2.85 / -2.92
-11.50574.62% (+8.59)
Jul 27, 20232023 (Q2)
-7.35 / -8.85
-14.137.23% (+5.25)
May 10, 20232023 (Q1)
-7.35 / -10.65
-34.9569.53% (+24.30)
Mar 15, 20232022 (Q4)
- / -10.50
-18.944.44% (+8.40)
Nov 09, 20222022 (Q3)
-15.90 / -11.51
-1836.08% (+6.49)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

AVGR Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 07, 2024$0.81$0.83+2.47%
Aug 08, 2024$1.20$1.22+1.67%
May 15, 2024$3.84$3.72-3.12%
Mar 20, 2024$3.30$2.92-11.52%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Avinger (AVGR) report earnings?
Avinger (AVGR) is schdueled to report earning on Mar 06, 2025, TBA Not Confirmed.
    What is Avinger (AVGR) earnings time?
    Avinger (AVGR) earnings time is at Mar 06, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is AVGR EPS forecast?
          AVGR EPS forecast for the fiscal quarter 2024 (Q4) is -$0.4.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis